AOD-9604 research overview AOD-9604 is a fragment-based peptide studied specifically for its structural relationship to a region of the growth hormone molecule associated with lipolytic activity
Australia, Canada, and EU In Australia, AOD9604 is classified as a prescription-only medication by the Therapeutic Goods Administration (TGA) (Poisons Standard Appendix D lists AOD9604
IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS Most side effects of B12/MIC are generally mild in nature and dissipate within a short time frame following administration
It is effective for muscle spasms and cramps
No effect on IGF-1, blood sugar, or cortisol
Studies have shown that 70% of Kenyan schoolchildren, 70% of East Indian adults, and 40% of Latin American residents are B12 deficient